Literature DB >> 6424741

Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence.

K S Sakariassen, M Ottenhof-Rovers, J J Sixma.   

Abstract

The role of divalent cations in platelet adherence to deendothelialized human arteries in flowing blood was investigated in an annular perfusion chamber. Spreading of platelets on the subendothelium was impaired below 30 microM of free Ca2+ ions (Ca2+). When Ca2+ was replaced by Mg2+, adherence was unchanged in perfusates without exogenous factor VIII-von Willebrand factor (FVIII-vWF), but the ability of FVIII-vWF to support platelet adherence was lost. Binding of FVIII-vWF to the vessel wall was independent of divalent cations, but bound FVIII-vWF was only able to mediate adherence after exposure to Ca2+. Pretreatment of FVIII-vWF with the calcium chelator EGTA (10 mM) resulted in loss of the ability to facilitate platelet adherence, while the ristocetin cofactor activity remained intact. Full restoration of the ability to mediate platelet adherence could only be obtained by prolonged dialysis against Ca2+ in the millimolar range. These data indicate that divalent cations have at least two separate roles to play in supporting platelet adherence: (1) platelet spreading on the subendothelium requires Ca2+ or Mg2+; (2) FVIII-vWF should be exposed to Ca2+ to obtain its optimal biologic activity in supporting platelet adherence.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424741

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Shear-induced platelet aggregation: 3D-grayscale microfluidics for repeatable and localized occlusive thrombosis.

Authors:  Michael T Griffin; Dongjune Kim; David N Ku
Journal:  Biomicrofluidics       Date:  2019-10-01       Impact factor: 2.800

2.  Citric Acid-Containing Dialysate and Survival Rate in the Dialysis Outcomes and Practice Patterns Study.

Authors:  Pablo Ureña-Torres; Brian Bieber; Fitsum Guebre-Egziabher; Rim Ossman; Michel Jadoul; Masaaki Inaba; Bruce M Robinson; Friedrich Port; Christian Jacquelinet; Christian Combe
Journal:  Kidney360       Date:  2021-02-04

Review 3.  Microfluidics and coagulation biology.

Authors:  Thomas V Colace; Garth W Tormoen; Owen J T McCarty; Scott L Diamond
Journal:  Annu Rev Biomed Eng       Date:  2013-05-03       Impact factor: 9.590

4.  Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit.

Authors:  Andrew Davenport; Ashita Tolwani
Journal:  NDT Plus       Date:  2009-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.